Edwards Lifesciences (EW)

R&D to Revenue

16.02%

Quarterly · Period ending:

EW logo

EW R&D to Revenue

Latest reported16.02%
EW Quarterly R&D/Revenue (7.26% → 16.02%)
High-resolution chart · PNG

EW r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences R&D to Revenue — Quarterly
Period endingR&D to Revenue
16.0195%
15.9711%
17.0553%
18.0735%
18.0264%
18.0222%
19.5627%
18.7094%
19.6695%
19.3022%
19.1172%
19.5271%
18.8113%
17.8953%
17.2217%
17.7104%
18.2546%
17.0444%
17.5077%
18.1652%
16.3735%
17.0146%
16.4219%
17.1356%
19.6865%
16.6032%
16.5148%
17.8702%
17.6557%
17.2608%
16.682%
17.8469%
16.3293%
16.0036%
16.4997%
17.395%
15.9658%
14.5671%
14.9668%
15.2827%
14.869%
14.6852%
14.6327%
16.4094%
15.8074%
14.6366%
13.5922%
14.4221%
15.493%
16.4242%
14.6642%
16.9693%
15.5646%
16.066%
14.6719%
16.4769%
15.3527%
14.939%
14.1097%
14.9503%
15.051%
14.5859%
14.2457%
15.1046%
13.8554%
13.2746%
13.9314%
13.7243%
12.6975%
12.7273%
11.5596%
11.5613%
10.8059%
11.0849%
11.4334%
11.821%
10.675%
10.905%
11.2952%
11.3581%
10.8118%
10.5058%
10.3324%
9.9626%
9.3726%
10.0361%
9.8693%
9.742%
8.8235%
8.9362%
8.4784%
8.1514%
8.2645%
8.9412%
8.7149%
9.3486%
9.6065%
9.4886%
9.0056%
9.4723%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.